4-butyrolactone has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coppa, GF; Giangola, M; Jacob, A; Khader, A; Kuncewitch, M; Nicastro, J; Wang, P; Yang, WL | 1 |
| Barie, PS; Cohen, SM; Darakchiev, B; Fantini, GA; Hariri, RJ; Siddiqi, FA | 1 |
2 other study(ies) available for 4-butyrolactone and Chronic Lung Injury
| Article | Year |
|---|---|
Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.
Topics: 4-Butyrolactone; Animals; Biomarkers; Combined Modality Therapy; Crystalloid Solutions; Enzyme Inhibitors; Fatty Acid Synthases; Fluid Therapy; Isotonic Solutions; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Rehydration Solutions; Resuscitation; Shock, Hemorrhagic; Treatment Outcome | 2016 |
Attenuation of acute lung injury caused by hind-limb ischemia-reperfusion injury by butyrolactone anti-inflammatory agent FL1003.
Topics: 4-Butyrolactone; Acute Disease; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Capillary Permeability; Disease Models, Animal; Drug Evaluation, Preclinical; Extravascular Lung Water; Hindlimb; Lipid Peroxidation; Lung; Lung Injury; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1997 |